UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders

Leukemia, 2021-10, Vol.35 (10), p.2771-2783

2021

Volltextzugriff (PDF)

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma

Epigenetics, 2014-11, Vol.9 (11), p.1511-1520

2014

Volltextzugriff (PDF)

Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients

Leukemia, 2019-08, Vol.33 (8), p.2022-2033

2019

Volltextzugriff (PDF)

Translational Potential of RNA Derived From Extracellular Vesicles in Multiple Myeloma

Frontiers in oncology, 2021-08, Vol.11, p.718502-718502

2021

Volltextzugriff (PDF)

Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma

International journal of molecular sciences, 2018-07, Vol.19 (7), p.1858

2018

Volltextzugriff (PDF)

Liquid biopsies for liquid tumors： emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies

Cancer biology & medicine, 2016-06, Vol.13 (2), p.215-225

2016

Volltextzugriff (PDF)

Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients

Haematologica (Roma), 2024-03, Vol.109 (3), p.974-978

2024

Volltextzugriff (PDF)

Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma

Blood cancer journal (New York), 2023-02, Vol.13 (1), p.25-25, Article 25

2023

Volltextzugriff (PDF)

Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma

Blood cancer journal (New York), 2023-09, Vol.13 (1), p.136-136, Article 136

2023

Volltextzugriff (PDF)

Mining the Plasma Cell Transcriptome for Novel Cell Surface Proteins

International journal of molecular sciences, 2018-07, Vol.19 (8), p.2161

2018

Volltextzugriff (PDF)

Control of KIT signalling in male germ cells: what can we learn from other systems?

Reproduction (Cambridge, England), 2009-11, Vol.138 (5), p.743-757

2009

Volltextzugriff (PDF)

Sperm chromatin structure assay versus sperm chromatin dispersion kits: Technical repeatability and choice of assisted reproductive technology procedure

Clinical and Experimental Reproductive Medicine, 2020, 46(4), , pp.277-283

2020

Volltextzugriff (PDF)

A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia

Haematologica (Roma), 2015-02, Vol.100 (2), p.e60-e62

2015

Volltextzugriff (PDF)

Circulating tumour DNA analysis in multiple myeloma

Oncotarget, 2017-10, Vol.8 (53), p.90610-90611

2017

Volltextzugriff (PDF)

Correction: Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders

Leukemia, 2021-10, Vol.35 (10), p.3037-3037

2021

Volltextzugriff (PDF)

Male age is associated with sperm DNA/chromatin integrity

The aging male, 2020-12, Vol.23 (5), p.822-829

2020

Volltextzugriff (PDF)

Targeting Bclxl Mitigates Mcl1 Chemoresistance in Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.2656-2656

2021

Volltextzugriff (PDF)

Circulating tumor DNA analysis and association with relapse in patients with primary refractory multiple myeloma receiving secondary salvage therapy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.8037-8037

2022

Volltextzugriff (PDF)

Cell Free MYC DNA Copy Number Identifies High-Risk Smouldering Myeloma and Newly Diagnosed Multiple Myeloma

Blood, 2023-11, Vol.142 (Supplement 1), p.878-878

2023

Volltextzugriff (PDF)

P-069 Liquid biopsy monitoring is more sensitive than alternative techniques in extramedullary multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S72-S73

2023

Volltextzugriff (PDF)

P-335 Small nucleotide, copy number and structural variants cooperate to hijack driver genes in extramedullary progression of myeloma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S223-S224

2023

Volltextzugriff (PDF)

Circulating RAS/RAF and DNA-Repair Gene Mutations Associates with High-Risk/Treatment Resistance in Primary Refractory Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.9933-9934

2022

Volltextzugriff (PDF)

Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma

Methods in molecular biology (Clifton, N.J.), 2021, Vol.2261, p.151

2021

Volltextzugriff (PDF)

Panobinostat (LBH589) in Combination with the β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both in Vitro and In Vivo

Blood, 2019-11, Vol.134 (Supplement_1), p.5540-5540

2019

Volltextzugriff (PDF)

Activin Bioactivity Affects Germ Cell Differentiation in the Postnatal Mouse Testis In Vivo1

Biology of reproduction, 2010-05, Vol.82 (5), p.980-990

2010

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(63)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma

Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients

Translational Potential of RNA Derived From Extracellular Vesicles in Multiple Myeloma

Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma

Liquid biopsies for liquid tumors： emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies

Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients

Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma

Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma

Mining the Plasma Cell Transcriptome for Novel Cell Surface Proteins

Control of KIT signalling in male germ cells: what can we learn from other systems?

Sperm chromatin structure assay versus sperm chromatin dispersion kits: Technical repeatability and choice of assisted reproductive technology procedure

A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia

Circulating tumour DNA analysis in multiple myeloma

Correction: Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders

Male age is associated with sperm DNA/chromatin integrity

Targeting Bclxl Mitigates Mcl1 Chemoresistance in Multiple Myeloma

Circulating tumor DNA analysis and association with relapse in patients with primary refractory multiple myeloma receiving secondary salvage therapy

Cell Free MYC DNA Copy Number Identifies High-Risk Smouldering Myeloma and Newly Diagnosed Multiple Myeloma

P-069 Liquid biopsy monitoring is more sensitive than alternative techniques in extramedullary multiple myeloma

P-335 Small nucleotide, copy number and structural variants cooperate to hijack driver genes in extramedullary progression of myeloma

Circulating RAS/RAF and DNA-Repair Gene Mutations Associates with High-Risk/Treatment Resistance in Primary Refractory Multiple Myeloma

Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma

Panobinostat (LBH589) in Combination with the β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both in Vitro and In Vivo

Activin Bioactivity Affects Germ Cell Differentiation in the Postnatal Mouse Testis In Vivo1

Suchergebnisse filtern